FR22C1051I2 - MIXTURES OF CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS - Google Patents

MIXTURES OF CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS

Info

Publication number
FR22C1051I2
FR22C1051I2 FR22C1051C FR22C1051C FR22C1051I2 FR 22C1051 I2 FR22C1051 I2 FR 22C1051I2 FR 22C1051 C FR22C1051 C FR 22C1051C FR 22C1051 C FR22C1051 C FR 22C1051C FR 22C1051 I2 FR22C1051 I2 FR 22C1051I2
Authority
FR
France
Prior art keywords
mixtures
immunomodulating agents
cyclosporine analogs
cyclosporine
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR22C1051C
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR22C1051I1 publication Critical patent/FR22C1051I1/en
Application granted granted Critical
Publication of FR22C1051I2 publication Critical patent/FR22C1051I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
FR22C1051C 2001-10-19 2022-10-14 MIXTURES OF CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS Active FR22C1051I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34620101P 2001-10-19 2001-10-19
PCT/CA2002/001560 WO2003033527A2 (en) 2001-10-19 2002-10-17 Cyclosporine analogue mixtures and their use as immunomodulating agents

Publications (2)

Publication Number Publication Date
FR22C1051I1 FR22C1051I1 (en) 2022-12-16
FR22C1051I2 true FR22C1051I2 (en) 2023-11-17

Family

ID=23358378

Family Applications (1)

Application Number Title Priority Date Filing Date
FR22C1051C Active FR22C1051I2 (en) 2001-10-19 2022-10-14 MIXTURES OF CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS

Country Status (37)

Country Link
US (2) US20110092669A1 (en)
EP (2) EP1436322B1 (en)
JP (4) JP2005511538A (en)
KR (1) KR100992850B1 (en)
CN (1) CN100344648C (en)
AR (1) AR036853A1 (en)
AT (1) ATE401339T1 (en)
AU (1) AU2002331510B2 (en)
BE (1) BE2022C547I2 (en)
BR (1) BR0213659A (en)
CA (2) CA2460685C (en)
CO (1) CO5570682A2 (en)
CY (1) CY1108410T1 (en)
DE (1) DE60227686D1 (en)
DK (1) DK1436322T3 (en)
EC (3) ECSP045060A (en)
ES (1) ES2310604T3 (en)
FI (1) FIC20220041I1 (en)
FR (1) FR22C1051I2 (en)
HK (1) HK1062567A1 (en)
HR (1) HRP20040353B1 (en)
IL (2) IL160762A0 (en)
LT (1) LTC1436322I2 (en)
MA (1) MA26337A1 (en)
ME (1) ME00487B (en)
MX (1) MXPA04003624A (en)
MY (1) MY187182A (en)
NO (2) NO331745B1 (en)
NZ (1) NZ531945A (en)
PL (1) PL210697B1 (en)
PT (1) PT1436322E (en)
RU (1) RU2337106C2 (en)
SI (1) SI1436322T1 (en)
TN (1) TNSN04069A1 (en)
UY (1) UY27502A1 (en)
WO (1) WO2003033527A2 (en)
ZA (1) ZA200402270B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2326040T3 (en) 2001-10-19 2009-09-29 Isotechnika Inc. SYNTHESIS OF CYCLOSPORINE ANALOGS.
ATE401339T1 (en) * 2001-10-19 2008-08-15 Isotechnika Inc MIXTURES OF CYCLOSPORINE ANALOGUES AND THEIR USE AS IMMUNE MODULATORS
TW200505946A (en) * 2003-04-08 2005-02-16 Hoffmann La Roche Process for preparation of cyclosporin a analog
TW200635954A (en) * 2004-12-17 2006-10-16 Isotechnika Inc Metabolites of cyclosporin analogs
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
MX2010003364A (en) 2007-10-08 2010-07-06 Lux Biosciences Inc Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors.
AU2010259184B2 (en) 2009-06-09 2015-08-13 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
MY165152A (en) 2010-12-15 2018-02-28 Contravir Pharmaceuticals Inc Cyclosporine analogue molecules modified at amino acid 1 and 3
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
US20210104302A1 (en) * 2016-11-30 2021-04-08 Schrödinger, Inc. Graphical user interface for chemical transition state calculations
US20180164221A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
WO2018106928A1 (en) 2016-12-08 2018-06-14 Contravir Pharmaceuticals, Inc. Treatment and prevention of hbv diseases by cyclosporine analogue molecules modified at amino acides 1 and 3
JP2020513280A (en) 2016-12-14 2020-05-14 プロジェニティ， インコーポレイテッド Treatment of digestive tract diseases with immunosuppressants
US10286036B2 (en) * 2017-05-12 2019-05-14 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
EP4201952A1 (en) 2021-12-21 2023-06-28 Curia Spain, S.A.U. Process for the controlled synthesis of voclosporin
WO2024052941A1 (en) * 2022-09-09 2024-03-14 Dr. Reddy's Laboratories Limited Improved process for the preparation of voclosporin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278545A (en) * 1979-09-12 1981-07-14 The Bendix Corporation Apparatus for separating solids and liquid components
CH670644A5 (en) * 1986-12-18 1989-06-30 Lonza Ag
US5162540A (en) * 1986-12-18 1992-11-10 Lonza Ltd. Process for the production of (+) biotin
ES2059558T3 (en) * 1987-06-17 1994-11-16 Sandoz Ag CYCLOSPORINS AND THEIR USE AS PHARMACEUTICAL PRODUCTS.
US5972630A (en) * 1991-08-19 1999-10-26 Dade Behring Marburg Gmbh Homogeneous immunoassays using enzyme inhibitors
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
US5939406A (en) * 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
ATE423130T1 (en) * 1997-10-08 2009-03-15 Isotechnika Inc DEUTERATED CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
ES2326040T3 (en) * 2001-10-19 2009-09-29 Isotechnika Inc. SYNTHESIS OF CYCLOSPORINE ANALOGS.
ATE401339T1 (en) * 2001-10-19 2008-08-15 Isotechnika Inc MIXTURES OF CYCLOSPORINE ANALOGUES AND THEIR USE AS IMMUNE MODULATORS

Also Published As

Publication number Publication date
MA26337A1 (en) 2004-10-01
ECSP045061A (en) 2004-08-27
CA2727642C (en) 2014-02-04
ES2310604T3 (en) 2009-01-16
PL370501A1 (en) 2005-05-30
ATE401339T1 (en) 2008-08-15
EP1436322A2 (en) 2004-07-14
IL160762A0 (en) 2004-08-31
AR036853A1 (en) 2004-10-06
JP2009197036A (en) 2009-09-03
EP1436322B1 (en) 2008-07-16
RU2004110941A (en) 2005-08-10
WO2003033527A2 (en) 2003-04-24
CN100344648C (en) 2007-10-24
JP2011006417A (en) 2011-01-13
SI1436322T1 (en) 2008-12-31
CA2460685A1 (en) 2003-04-24
NO2022042I1 (en) 2022-10-14
HRP20040353A2 (en) 2005-04-30
CO5570682A2 (en) 2005-10-31
LTPA2022521I1 (en) 2022-11-10
TNSN04069A1 (en) 2006-06-01
CN1571794A (en) 2005-01-26
EP1816138A1 (en) 2007-08-08
JP2013136597A (en) 2013-07-11
AU2002331510B2 (en) 2008-05-01
BR0213659A (en) 2004-10-26
IL160762A (en) 2010-11-30
JP5272140B2 (en) 2013-08-28
HK1062567A1 (en) 2004-11-12
ME00487B (en) 2011-10-10
UY27502A1 (en) 2003-04-30
MY187182A (en) 2021-09-08
LTC1436322I2 (en) 2023-06-26
FIC20220041I1 (en) 2022-10-14
KR100992850B1 (en) 2010-11-09
US20110092669A1 (en) 2011-04-21
DK1436322T3 (en) 2008-11-03
CY1108410T1 (en) 2012-05-23
NZ531945A (en) 2006-01-27
PT1436322E (en) 2008-10-23
RU2337106C2 (en) 2008-10-27
PL210697B1 (en) 2012-02-29
US20140288266A1 (en) 2014-09-25
CA2460685C (en) 2014-05-27
JP2005511538A (en) 2005-04-28
WO2003033527A3 (en) 2003-10-16
NO20042029L (en) 2004-05-14
KR20050037421A (en) 2005-04-21
ZA200402270B (en) 2005-05-25
ECSP045059A (en) 2004-07-23
MXPA04003624A (en) 2004-12-06
NO331745B1 (en) 2012-03-19
BE2022C547I2 (en) 2022-10-19
FR22C1051I1 (en) 2022-12-16
ECSP045060A (en) 2004-07-23
DE60227686D1 (en) 2008-08-28
CA2727642A1 (en) 2003-04-24
HRP20040353B1 (en) 2012-10-31

Similar Documents

Publication Publication Date Title
FR22C1051I2 (en) MIXTURES OF CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
MA27126A1 (en) 3'PROMEDICAMENTS OF 2'-DESOXY- β-L-NUCLEOSIDES
FR2765801B1 (en) USE OF ARBUTINE MONOESTERS AS DEPIGMENTING AGENTS
DE69811436D1 (en) Improved processability of silica-filled rubber compositions
PT996430E (en) COMPOSITIONS OF NUCLEOTIDIC ANALOGS
DE59910836D1 (en) DERMAL APPLICABLE WATER-BASED FORMULATIONS OF PARASITICIDES
IL160190A0 (en) Use of copolymer to produce a galenic form containining a peptide or a protein as active agent
FR2818614B1 (en) SUSPENSION PART OF A TURBO-JET
AU2517399A (en) Utilization of substituted sulfonamides as antiviral agents and novel substances
HUP0004799A3 (en) Use of electrolyte mixtures as sequestering agents
FR2799755B1 (en) PREPARATION OF PERFLUOROUS ALCOYLSUFONYL CHLORIDE IN SULFUR ALPHA
NO20025964L (en) New interferon for the treatment of multiple sclerosis
ID19294A (en) SELF-MIXED PLAYER FORMULATION
FI990032A (en) Ocular hypotensive active compositions
AR026890A1 (en) COMPOSITIONS OF TENOCITS, PREPARATIONS AND USES
EP1406921A4 (en) Hypoglycaemic peptides and methods of use thereof
FR2810477B1 (en) REPETITIVE GAMES GENERATOR OF SPREADING SEQUENCES
TW484436U (en) Improved structure of roque stick
ITVE20010030A1 (en) HIGH STABILITY ARTICULATED SKI
IT1302512B1 (en) STRUCTURE OF PUZZLES
ITPD980228A1 (en) STRUCTURE OF PUZZLES
SI1276491T1 (en) Tamandarin and didemnin analogs and methods of making and using them
UA3629S (en) DECORATION OF THE GAME "TELEFORTUNA"
TW415544U (en) Improved structure of oil mist blast fan
AP2007003992A0 (en) 3'-Prodrugs of 2'-deoxy-beta-l-nucleosides